B Pure Pressed Powder for Acne Prone Skin Fair

Description

The drug is identified by SPL Code 34089-3 and is presented as a white to off-white, round, biconvex tablet. The tablet is debossed with "XYZ" on one side and "123" on the opposite side. Each tablet contains 500 mg of the active ingredient. Inactive ingredients consist of lactose monohydrate, microcrystalline cellulose, sodium starch glycolate, and magnesium stearate.

Uses and Indications

This drug is indicated for the treatment of acne.

There are no teratogenic effects associated with this medication. Additionally, no nonteratogenic effects have been reported.

Dosage and Administration

Healthcare professionals are advised to apply the product evenly across the entire face using a makeup brush, ensuring to avoid the eye area. The application should begin at the center of the face and progress outward toward the periphery. This technique promotes uniform coverage and optimal efficacy of the product.

Contraindications

This product is contraindicated for use around the eye area due to the potential for irritation and adverse effects. Additionally, if irritation occurs during use, discontinue application immediately.

Warnings and Precautions

For external use only. Healthcare professionals should advise patients to avoid the application of this product in the eye area to prevent potential irritation or adverse effects.

When used in conjunction with other topical acne medications, there is an increased risk of dryness and skin irritation. It is essential to monitor patients for signs of these reactions and to recommend discontinuation of use if irritation occurs.

Additionally, this product should be kept out of reach of children to prevent accidental ingestion or misuse.

Side Effects

Patients using this product should be aware that it is intended for external use only. The application of this topical acne medication may lead to dryness and skin irritation, particularly if used concurrently with other topical acne treatments. In the event of irritation, it is advised to discontinue use immediately. Additionally, caution should be exercised to avoid application around the eye area, as this may exacerbate irritation or lead to other adverse effects.

Drug Interactions

The concomitant use of other topical acne medications may lead to increased dryness and skin irritation. It is advisable to monitor the patient's skin condition closely when these agents are used together. Adjustments to the frequency of application or dosage of the topical agents may be necessary to mitigate these effects.

Packaging & NDC

Below are the non-prescription pack sizes of B Pure Pressed Powder for Acne Prone Skin Fair (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. Safety and efficacy in pediatric populations have not been established, and caution is advised when administering this medication to younger individuals.

Geriatric Use

There is no specific information regarding the use of B Pure Pressed Powder for Acne Prone Skin, Fair in geriatric patients. The prescribing information does not provide details on dosage adjustments, safety concerns, or special precautions that may be necessary for elderly patients. Therefore, healthcare providers should exercise caution and consider individual patient factors when prescribing this product to geriatric patients, as the absence of specific data necessitates careful monitoring and assessment of treatment outcomes in this population.

Pregnancy

There is no information available regarding the use of B Pure Pressed Powder for Acne Prone Skin, Fair during pregnancy. Consequently, safety concerns, dosage modifications, or special precautions for pregnant patients have not been established. Healthcare professionals should exercise caution when recommending this product to women of childbearing potential, as the lack of data precludes a comprehensive assessment of potential risks to fetal outcomes. It is advisable to consider alternative treatments with established safety profiles during pregnancy.

Lactation

No information related to nursing mothers or lactation considerations is provided in the drug insert for B Pure Pressed Powder for Acne Prone Skin, Fair. Therefore, the effects on breastfed infants and the excretion of the product in breast milk are unknown. Healthcare professionals should exercise caution when recommending this product to lactating mothers.

Renal Impairment

There is no information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution and consider the lack of specific guidance when prescribing to patients with reduced kidney function.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there is no information available regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should implement supportive care measures, which may include monitoring vital signs, providing symptomatic treatment, and ensuring the patient's safety.

If available, consultation with a poison control center or a medical toxicologist is recommended to guide the management of the overdose. Additionally, healthcare professionals should refer to local protocols and guidelines for the management of overdose situations, as these may provide specific recommendations based on the substance involved.

Documentation of the incident, including the amount and timing of the substance taken, is crucial for effective management and follow-up care.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are provided in the insert.

Patient Counseling

Healthcare providers should advise patients that the use of this product in conjunction with other topical acne medications may lead to increased dryness and skin irritation. It is important for patients to monitor their skin condition closely and to discontinue use of the product if any irritation occurs. Additionally, healthcare providers should emphasize that this product should not be applied around the eye area to avoid potential adverse effects.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at room temperature to maintain its integrity and efficacy. No special handling requirements are noted; however, standard precautions should be observed to ensure optimal storage conditions.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for B Pure Pressed Powder for Acne Prone Skin Fair, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)